This drug is a small molecule inhibitor of KAT6, a histone acetyltransferase (“HAT”) that is dysregulated in several cancers, including breast, lung, and ovarian cancers. The drug aims to inhibit KAT6, blocking ERΞ± at the transcriptional level, which could be beneficial in the treatment of ER+/HER2- breast cancer.
Γ